← Evidence map

ReviewAdvances in therapy2026

Brixadi for Stimulant Use Disorder: Evolving Pharmacologic Considerations and Clinical Implications.

M Farris Sawaya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42720725